glp 1 reduces inflammation Anti-inflammatory role of glucagon-like peptide receptor agonists and its clinical implications Antiinflammatory actions of glucagon-like peptide-1–based
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Finger B.C., Dinan T.G., Cryan J.F
Additionally, these medications are covered for the treatment of childhood obesity under Medicaids Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit
Not opinions
In clinical trials, the results are modest but real
Most of the research published so far has been in animal models or very early-phase human studies
legal proceedings involving these medications
